|1.||Pasquale, Elena B: 2 articles (10/2015 - 02/2012)|
|2.||King, Christopher: 1 article (10/2015)|
|3.||Salotto, Matt: 1 article (10/2015)|
|4.||Singh, Deo R: 1 article (10/2015)|
|5.||Zhou, Xiang Yang: 1 article (10/2015)|
|6.||Hristova, Kalina: 1 article (10/2015)|
|7.||Ahmed, Fozia: 1 article (10/2015)|
|8.||Cao, QingQing: 1 article (10/2015)|
|9.||Lamberto, Ilaria: 1 article (01/2015)|
|10.||Forse, Garry Jason: 1 article (01/2015)|
01/01/2015 - "The human EphA3 receptor is widely upregulated in the tumor microenvironment and is highly expressed in some types of cancer cells. "
08/08/2012 - "At least two cancer-associated EPHA3 somatic mutations functioned as dominant inhibitors of the normal (wild type) EPHA3 protein. "
02/15/2013 - "One such candidate is the EPHA3 receptor tyrosine kinase, a gene commonly mutated in human cancer. "
02/21/2012 - "Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms."
08/08/2012 - "Cancer genome sequencing efforts recently identified EPHA3, which encodes the EPHA3 receptor tyrosine kinase, as one of the most frequently mutated genes in lung cancer. "
|2.||Spinal Cord Injuries (Spinal Cord Injury)
08/01/2005 - "Upregulation of EphA3 receptor after spinal cord injury."
|4.||Lung Neoplasms (Lung Cancer)
|5.||Hepatocellular Carcinoma (Hepatoma)
|1.||Protein-Tyrosine Kinases (Tyrosine Kinase)